Early Phase 1 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 65 years old or older and able to give your own consent to participate
- You have scored between 19 and 23 on a standard memory and thinking test, which suggests mild Alzheimer's disease
- The trial aims to include roughly equal numbers of men and women
Who may not be able to join:
- You are not able to give your own consent to take part
- You have another condition affecting the brain or nervous system (other than Alzheimer's)
- You have a significant mental health condition, such as severe depression
- You have certain stomach, digestive, or metabolic health conditions
- You have a history of alcohol or drug dependence
- You have taken antibiotic tablets, capsules, or injections in the last 6 months
- You currently take steroid medications (such as prednisolone or similar)
- You take medications that stimulate or boost the immune system
- You take medications that suppress or weaken the immune system
- You have taken probiotic supplements or products in the last 6 months
- You have a weakened immune system for any reason
- You have a significant heart condition affecting the structure of the heart
- You have a low level of white blood cells (which help fight infection)
- You are currently receiving radiation treatment
- You have an active disease or condition affecting your intestines or bowel
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +35722471903
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Level of inflammatory markers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.